Rsocialform - Geriatria, Lda
8
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Cognitive Stimulation in Older Adults With Alzheimer's Disease
Role: lead
Effectiveness of a 3-month Individual Reminiscence Therapy Program in Older Adults With Alzheimer's Disease
Role: lead
Effect of Individual Cognitive Stimulation on Memory and Executive Function in Older Adults With Alzheimer's Disease
Role: lead
Older Adults' Perceptions of the Impact COVID-19 Pandemic
Role: lead
Major Memory 2: A Long-term Group Cognitive Stimulation Program
Role: lead
Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders
Role: lead
Comparison Study of the Different Abbreviated Versions of the Geriatric Depression Scale
Role: lead
Multicentre Study About the Effect of Individual Reminiscence Therapy
Role: lead
All 8 trials loaded